NCT02187783 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 106
- units
- Participants
- groups
- description
- LEE011 600 mg (hard gelatin capsules) was administered orally once daily for 3 weeks on/1 week off. A complete treatment cycle was defined as 28 days.
- id
- BG000
- title
- Ribociclib 600 mg
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 13.52
- value
- 60.5
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 56
- title
- Female
- measurements
- group Id
- BG000
- value
- 50
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 90
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 4
- title
- Black or African American
- categories
- measurements
- group Id
- BG000
- value
- 5
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 7
- title
- Other
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Adrenals
- measurements
- group Id
- BG000
- value
- 7
- title
- Bladder
- measurements
- group Id
- BG000
- value
- 7
- title
- Breast-triple negative
- measurements
- group Id
- BG000
- value
- 1
- title
- Cervix
- measurements
- group Id
- BG000
- value
- 2
- title
- Cholangio
- measurements
- group Id
- BG000
- value
- 1
- title
- Chordoma
- measurements
- group Id
- BG000
- value
- 2
- title
- Colorectal
- measurements
- group Id
- BG000
- value
- 3
- title
- Esophagus
- measurements
- group Id
- BG000
- value
- 1
- title
- Gall bladder ducts
- measurements
- group Id
- BG000
- value
- 4
- title
- Gastroesophageal junction
- measurements
- group Id
- BG000
- value
- 1
- title
- Gastrointestinal stromal tumor
- measurements
- group Id
- BG000
- value
- 4
- title
- Head and neck non-squamous cell carcinoma
- description
- Primary tumor type was sponsor adjudicated.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Primary tumor type
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 61
- title
- Prior antineoplastic radiotherapy
- categories
- measurements
- group Id
- BG000
- value
- 92
- title
- Prior antineoplastic surgery
- categories
- measurements
- group Id
- BG000
- value
- 29
- title
- Liver metastasis
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Number of participants who had radiotherapy, surgery and liver metastasis
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 36
- title
- Performance status = 0
- categories
- measurements
- group Id
- BG000
- value
- 70
- title
- Performance status = 1
- description
- ECOG: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g. light housework, office work; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4 = Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5 = Dead.
- param Type
- NUMBER
- title
- Eastern Cooperative Oncology Group (ECOG) Performance Status for participants
- unit Of Measure
- participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 106
- units
- Participants
- groups
- description
- LEE011 600 mg (hard gelatin capsules) was administered orally once daily for 3 weeks on/1 week off. A complete treatment cycle was defined as 28 days.
- id
- BG000
- title
- Ribociclib 600 mg
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 13.52
- value
- 60.5
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 56
- title
- Female
- measurements
- group Id
- BG000
- value
- 50
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 90
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 4
- title
- Black or African American
- categories
- measurements
- group Id
- BG000
- value
- 5
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 7
- title
- Other
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Adrenals
- measurements
- group Id
- BG000
- value
- 7
- title
- Bladder
- measurements
- group Id
- BG000
- value
- 7
- title
- Breast-triple negative
- measurements
- group Id
- BG000
- value
- 1
- title
- Cervix
- measurements
- group Id
- BG000
- value
- 2
- title
- Cholangio
- measurements
- group Id
- BG000
- value
- 1
- title
- Chordoma
- measurements
- group Id
- BG000
- value
- 2
- title
- Colorectal
- measurements
- group Id
- BG000
- value
- 3
- title
- Esophagus
- measurements
- group Id
- BG000
- value
- 1
- title
- Gall bladder ducts
- measurements
- group Id
- BG000
- value
- 4
- title
- Gastroesophageal junction
- measurements
- group Id
- BG000
- value
- 1
- title
- Gastrointestinal stromal tumor
- measurements
- group Id
- BG000
- value
- 4
- title
- Head and neck non-squamous cell carcinoma
- description
- Primary tumor type was sponsor adjudicated.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Primary tumor type
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 61
- title
- Prior antineoplastic radiotherapy
- categories
- measurements
- group Id
- BG000
- value
- 92
- title
- Prior antineoplastic surgery
- categories
- measurements
- group Id
- BG000
- value
- 29
- title
- Liver metastasis
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Number of participants who had radiotherapy, surgery and liver metastasis
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 36
- title
- Performance status = 0
- categories
- measurements
- group Id
- BG000
- value
- 70
- title
- Performance status = 1
- description
- ECOG: 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g. light housework, office work; 2 = Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours; 3 = Capable of only limited self-care, confined to bed or chair more than 50% of waking hours; 4 = Completely disabled. Cannot carry on any self-care. Totally confined to bed or chair; 5 = Dead.
- param Type
- NUMBER
- title
- Eastern Cooperative Oncology Group (ECOG) Performance Status for participants
- unit Of Measure
- participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle